1-2 of 2
Gloria S. Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma

Levent Mutlu, Diego D. Manavella, Stefania Bellone, Blair McNamara, Justin A. Harold, Dennis Mauricio, Eric R. Siegel, Natalia Buza, Pei Hui, Tobias Max Philipp Hartwich, Yang Yang-Hartwich, Cem Demirkiran, Miguel Skyler Z. Verzosa, Gary Altwerger, Elena S. Ratner, Gloria S. Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter R. Dottino, Peter E. Schwartz, Alessandro D. Santin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12): 1404–1412.
https://doi.org/10.1158/1535-7163.MCT-23-0126
Published: 01 December 2023
View article titled, <em>In Vivo</em> and <em>In Vitro</em> Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma
Open the PDF for <em>In Vivo</em> and <em>In Vitro</em> Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma in another window
Journal Articles

In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

Gary Altwerger, Elena Bonazzoli, Stefania Bellone, Tomomi Egawa-Takata, Gulden Menderes, Francesca Pettinella, Anna Bianchi, Francesco Riccio, Jacqueline Feinberg, Luca Zammataro, Chanhee Han, Ghanshyam Yadav, Katherine Dugan, Ashley Morneault, Jose F. Ponte, Natalia Buza, Pei Hui, Serena Wong, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Gloria S. Huang, Masoud Azodi, Peter E. Schwartz, Alessandro D. Santin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (5): 1003–1011.
https://doi.org/10.1158/1535-7163.MCT-17-0930
Published: 30 April 2018
View article titled, <em>In Vitro</em> and <em>In Vivo</em> Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers
Open the PDF for <em>In Vitro</em> and <em>In Vivo</em> Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers in another window
Includes: Supplementary data